Real-life contemporary vitamin K antagonist is still associated with very low time in therapeutic range despite strict international normalized ratio monitoring: Results of big data analysis.
François-Xavier GoudotEdith Martins-MeuneCamille Chenevier-GobeauxJean-Jacques MouradChristophe MeunePublished in: Journal of clinical pharmacy and therapeutics (2022)
VKAs are still frequently prescribed in this era of direct oral anticoagulants. The low TTR cannot be explained by inadequate INR monitoring.